Stifel Financial’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $1.53M | Buy |
|
|||||
|
2023
Q1 | $1.35M | Buy |
|
|||||
|
2022
Q4 | $409K | Buy |
|
|||||
|
2022
Q3 | $256K | Sell |
|
|||||
|
2022
Q2 | $317K | Sell |
|
|||||
|
2022
Q1 | $347K | Buy |
|
|||||
|
2021
Q4 | $253K | Sell |
|
|||||
|
2021
Q3 | $4.46M | Sell |
|
|||||
|
2021
Q2 | $6.33M | Buy |
|
|||||
|
2021
Q1 | $4.2M | Buy |
|
|||||
|
2020
Q4 | $4.81M | Buy |
|
|||||
|
2020
Q3 | $2.97M | Sell |
|
|||||
|
2020
Q2 | $5.61M | Buy |
|
|||||
|
2020
Q1 | $5.13M | Buy |
|
|||||
|
2019
Q4 | $6.21M | Sell |
|
|||||
|
2019
Q3 | $2.49M | Buy |
|
|||||
|
2019
Q2 | $2.88M | Sell |
|
|||||
|
2019
Q1 | $2.75M | Buy |
|
|||||
|
2018
Q4 | $1.61M | Sell |
|
|||||
|
2018
Q3 | $2.55M | Buy |
|
|||||
|
2018
Q2 | $997K | Buy |
|
|||||
|
2018
Q1 | $575K | Buy |
|
|||||
|
2017
Q4 | $229K | Buy |
|